Clinical Study to Evaluate Effect on QT/QTc Interval After Multiple Dose of Celecoxib
NCT03822520
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
28
Enrollment
OTHER
Sponsor class
Conditions
Qt Interval, Variation in
Interventions
DRUG:
Celecoxib
DRUG:
Moxifloxacin
OTHER:
Water
Sponsor
Samsung Medical Center